{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T04:03:50Z","timestamp":1784606630833,"version":"3.55.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1-3","license":[{"start":{"date-parts":[[2017,6,26]],"date-time":"2017-06-26T00:00:00Z","timestamp":1498435200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Microenvironment"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s12307-017-0195-8","type":"journal-article","created":{"date-parts":[[2017,6,26]],"date-time":"2017-06-26T14:06:46Z","timestamp":1498486006000},"page":"39-48","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Human Metaplastic Breast Carcinoma and Decorin"],"prefix":"10.1007","volume":"10","author":[{"given":"Pia","family":"Bostr\u00f6m","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annele","family":"Sainio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalja","family":"Eig\u0117lien\u0117","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Jokilammi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Elenius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilkka","family":"Koskivuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1061-6779","authenticated-orcid":false,"given":"Hannu","family":"J\u00e4rvel\u00e4inen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,26]]},"reference":[{"key":"195_CR1","unstructured":"Reis-Filho J, Lakhani S, Gobbi H, Sneige N (2012) Metaplastic carcinoma. WHO classification of tumours of the breast. In: Lakhani S, Ellis I, Schnitt S, Tan P, van der Vijver M (eds). Lyon, pp 34-38"},{"key":"195_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/2047-783X-19-14","volume":"19","author":"Y Kang","year":"2014","unstructured":"Kang Y, Kang S, Li Q, Zheng X (2014) Mixed epithelial and mesenchymal metaplastic carcinoma (carcinosarcoma) of the breast: a case report. Eur J Med Res 19:14. doi: 10.1186\/2047-783X-19-14","journal-title":"Eur J Med Res"},{"key":"195_CR3","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1159\/000441288","volume":"10","author":"MA Fernandez Perez","year":"2015","unstructured":"Fernandez Perez MA, Viqueira Rodriguez I, Tello Royloa A, Martinez Guisasola J (2015) Metaplastic breast carcinoma with unusual presentation: review of three cases. Breast Care (Basel) 10:404\u2013407","journal-title":"Breast Care (Basel)"},{"key":"195_CR4","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/modpathol.2010.82","volume":"23","author":"FC Geyer","year":"2010","unstructured":"Geyer FC, Lambros MB, Natrajan R, Mehta R, Mackay A, Savage K, Parry S, Ashworth A, Badve S, Reis-Filho JS (2010) Genomic and immunohistochemical analysis of adenosquamous carcinoma of the breast. Mod Pathol 23:951\u2013960","journal-title":"Mod Pathol"},{"key":"195_CR5","first-page":"706162","volume":"2012","author":"DR Shah","year":"2012","unstructured":"Shah DR, Tseng WH, Martinez SR (2012) Treatment options for metaplastic breast cancer. ISRN Oncol 2012:706162","journal-title":"ISRN Oncol"},{"key":"195_CR6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s10549-011-1686-9","volume":"130","author":"IC Chen","year":"2011","unstructured":"Chen IC, Lin CH, Huang CS, Lien HC, Hsu C, Kuo WH, Lu YS, Cheng AL (2011) Lack of efficacy to systemic chemotherapy for treatment of metaplastic carcinoma of the breast in the modern era. Breast Cancer Res Treat 130:345\u2013351","journal-title":"Breast Cancer Res Treat"},{"key":"195_CR7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1477-7819-11-129","volume":"11","author":"Y Song","year":"2013","unstructured":"Song Y, Liu X, Zhang G, Song H, Ren Y, He X, Wang Y, Zhang J, Zhang Y, Sun S, Liang X, Sun Q, Pang D (2013) Unique clinicopathological features of metaplastic breast carcinoma compared with invasive ductal carcinoma and poor prognostic indicators. World J Surg Oncol 11:129","journal-title":"World J Surg Oncol"},{"key":"195_CR8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1658-3876(10)50041-4","volume":"3","author":"T Chien","year":"2010","unstructured":"Chien T, Chou J, Chang T, Lin C (2010) Successful treatment of biphasic metaplastic sarcomatoid carcinoma of the breast by evaluation of immunohistochemical markers. Hematol Oncol Stem Cell Ther 3:89\u201393","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"195_CR9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11912-014-0431-z","volume":"17","author":"S Abouharb","year":"2015","unstructured":"Abouharb S, Moulder S (2015) Metaplastic breast cancer: clinical overview and molecular aberrations for potential targeted therapy. Curr Oncol Rep 17:10","journal-title":"Curr Oncol Rep"},{"key":"195_CR10","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1634\/theoncologist.2014-0108","volume":"19","author":"MV Dieci","year":"2014","unstructured":"Dieci MV, Orvieto E, Dominici M, Conte P, Guarneri V (2014) Rare breast cancer subtypes: histological, molecular, and clinical peculiarities. Oncologist 19:805\u2013813","journal-title":"Oncologist"},{"key":"195_CR11","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/bjc.2014.592","volume":"112","author":"EA Rakha","year":"2015","unstructured":"Rakha EA, Tan PH, Varga Z, Tse GM, Shaaban AM, Climent F, van Deurzen CH, Purnell D, Dodwell D, Chan T, Ellis IO (2015) Prognostic factors in metaplastic carcinoma of the breast: a multi-institutional study. Br J Cancer 112:283\u2013289","journal-title":"Br J Cancer"},{"key":"195_CR12","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1158\/0008-5472.CAN-08-3441","volume":"69","author":"BT Hennessy","year":"2009","unstructured":"Hennessy BT, Gonzalez-Angulo AM, Stemke-Hale K, Gilcrease MZ, Krishnamurthy S, Lee JS, Fridlyand J, Sahin A, Agarwal R, Joy C, Liu W, Stivers D, Baggerly K, Carey M, Lluch A, Monteagudo C, He X, Weigman V, Fan C, Palazzo J, Hortobagyi GN, Nolden LK, Wang NJ, Valero V, Gray JW, Perou CM, Mills GB (2009) Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res 69:4116\u20134124","journal-title":"Cancer Res"},{"key":"195_CR13","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/modpathol.2011.167","volume":"25","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Toy KA, Kleer CG (2012) Metaplastic breast carcinomas are enriched in markers of tumor-initiating cells and epithelial to mesenchymal transition. Mod Pathol 25:178\u2013184","journal-title":"Mod Pathol"},{"key":"195_CR14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57\u201370","journal-title":"Cell"},{"key":"195_CR15","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/PPO.0000000000000127","volume":"21","author":"Z Werb","year":"2015","unstructured":"Werb Z, Lu P (2015) The role of stroma in tumor development. Cancer J 21:250\u2013253","journal-title":"Cancer J"},{"key":"195_CR16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","volume":"21","author":"D Hanahan","year":"2012","unstructured":"Hanahan D, Coussens LM (2012) Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 21:309\u2013322","journal-title":"Cancer Cell"},{"key":"195_CR17","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1083\/jcb.201102147","volume":"196","author":"P Lu","year":"2012","unstructured":"Lu P, Weaver VM, Werb Z (2012) The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol 196:395\u2013406","journal-title":"J Cell Biol"},{"key":"195_CR18","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.semcancer.2013.08.007","volume":"23","author":"V Catalano","year":"2013","unstructured":"Catalano V, Turdo A, Di Franco S, Dieli F, Todaro M, Stassi G (2013) Tumor and its microenvironment: a synergistic interplay. Semin Cancer Biol 23:522\u2013532","journal-title":"Semin Cancer Biol"},{"issue":"Suppl 2","key":"195_CR19","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/j.breast.2013.07.012","volume":"22","author":"T Oskarsson","year":"2013","unstructured":"Oskarsson T (2013) Extracellular matrix components in breast cancer progression and metastasis. Breast 22(Suppl 2):S66\u2013S72","journal-title":"Breast"},{"key":"195_CR20","first-page":"276","volume":"1855","author":"AD Theocharis","year":"2015","unstructured":"Theocharis AD, Skandalis SS, Neill T, Multhaupt HA, Hubo M, Frey H, Gopal S, Gomes A, Afratis N, Lim HC, Couchman JR, Filmus J, Sanderson RD, Schaefer L, Iozzo RV, Karamanos NK (2015) Insights into the key roles of proteoglycans in breast cancer biology and translational medicine. Biochim Biophys Acta 1855:276\u2013300","journal-title":"Biochim Biophys Acta"},{"key":"195_CR21","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2015.11.001","volume":"97","author":"AD Theocharis","year":"2016","unstructured":"Theocharis AD, Skandalis SS, Gialeli C, Karamanos NK (2016) Extracellular matrix structure. Adv Drug Deliv Rev 97:4\u201327","journal-title":"Adv Drug Deliv Rev"},{"key":"195_CR22","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1124\/pr.109.001289","volume":"61","author":"H J\u00e4rvel\u00e4inen","year":"2009","unstructured":"J\u00e4rvel\u00e4inen H, Sainio A, Koulu M, Wight TN, Penttinen R (2009) Extracellular matrix molecules: potential targets in pharmacotherapy. Pharmacol Rev 61:198\u2013223","journal-title":"Pharmacol Rev"},{"key":"195_CR23","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1242\/jcs.116392","volume":"125","author":"FR Balkwill","year":"2012","unstructured":"Balkwill FR, Capasso M, Hagemann T (2012) The tumor microenvironment at a glance. J Cell Sci 125:5591\u20135596","journal-title":"J Cell Sci"},{"key":"195_CR24","doi-asserted-by":"crossref","unstructured":"Sainio A, J\u00e4rvel\u00e4inen H (2014) Extracellular matrix macromolecules: potential tools and targets in cancer gene therapy. Mol Cell Ther 2:14-8426-2-14. eCollection 2014","DOI":"10.1186\/2052-8426-2-14"},{"key":"195_CR25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.canlet.2015.07.039","volume":"368","author":"L Hui","year":"2015","unstructured":"Hui L, Chen Y (2015) Tumor microenvironment: sanctuary of the devil. Cancer Lett 368:7\u201313","journal-title":"Cancer Lett"},{"key":"195_CR26","doi-asserted-by":"crossref","first-page":"4824573","DOI":"10.1155\/2016\/4824573","volume":"2016","author":"F Cammarota","year":"2016","unstructured":"Cammarota F, Laukkanen MO (2016) Mesenchymal stem\/stromal cells in stromal evolution and cancer progression. Stem Cells Int 2016:4824573","journal-title":"Stem Cells Int"},{"key":"195_CR27","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1742-4658.2012.08529.x","volume":"279","author":"N Afratis","year":"2012","unstructured":"Afratis N, Gialeli C, Nikitovic D, Tsegenidis T, Karousou E, Theocharis AD, Pavao MS, Tzanakakis GN, Karamanos NK (2012) Glycosaminoglycans: key players in cancer cell biology and treatment. FEBS J 279:1177\u20131197","journal-title":"FEBS J"},{"key":"195_CR28","doi-asserted-by":"crossref","first-page":"124321","DOI":"10.1155\/2014\/124321","volume":"2014","author":"D Nikitovic","year":"2014","unstructured":"Nikitovic D, Kouvidi K, Voudouri K, Berdiaki A, Karousou E, Passi A, Tzanakakis GN (2014) The motile breast cancer phenotype roles of proteoglycans\/glycosaminoglycans. Biomed Res Int 2014:124321","journal-title":"Biomed Res Int"},{"key":"195_CR29","doi-asserted-by":"crossref","first-page":"21305","DOI":"10.1074\/jbc.R800020200","volume":"283","author":"L Schaefer","year":"2008","unstructured":"Schaefer L, Iozzo RV (2008) Biological functions of the small leucine-rich proteoglycans: from genetics to signal transduction. J Biol Chem 283:21305\u201321309","journal-title":"J Biol Chem"},{"key":"195_CR30","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1074\/jbc.274.8.4489","volume":"274","author":"RV Iozzo","year":"1999","unstructured":"Iozzo RV, Moscatello DK, McQuillan DJ, Eichstetter I (1999) Decorin is a biological ligand for the epidermal growth factor receptor. J Biol Chem 274:4489\u20134492","journal-title":"J Biol Chem"},{"key":"195_CR31","doi-asserted-by":"crossref","first-page":"266","DOI":"10.5732\/cjc.012.10301","volume":"32","author":"XL Bi","year":"2013","unstructured":"Bi XL, Yang W (2013) Biological functions of decorin in cancer. Chin J Cancer 32:266\u2013269","journal-title":"Chin J Cancer"},{"key":"195_CR32","doi-asserted-by":"crossref","first-page":"654765","DOI":"10.1155\/2015\/654765","volume":"2015","author":"TA J\u00e4rvinen","year":"2015","unstructured":"J\u00e4rvinen TA, Prince S (2015) Decorin: a growth factor antagonist for tumor growth inhibition. Biomed Res Int 2015:654765","journal-title":"Biomed Res Int"},{"key":"195_CR33","doi-asserted-by":"crossref","first-page":"35153","DOI":"10.1074\/jbc.M006821200","volume":"275","author":"M Santra","year":"2000","unstructured":"Santra M, Eichstetter I, Iozzo RV (2000) An anti-oncogenic role for decorin. Down-regulation of ErbB2 leads to growth suppression and cytodifferentiation of mammary carcinoma cells. J Biol Chem 275:35153\u201335161","journal-title":"J Biol Chem"},{"key":"195_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejcb.2012.08.004","volume":"92","author":"DD Sofeu Feugaing","year":"2013","unstructured":"Sofeu Feugaing DD, G\u00f6tte M, Viola M (2013) More than matrix: the multifaceted role of decorin in cancer. Eur J Cell Biol 92:1\u201311","journal-title":"Eur J Cell Biol"},{"key":"195_CR35","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.matbio.2013.11.004","volume":"35","author":"Z Horv\u00e1th","year":"2014","unstructured":"Horv\u00e1th Z, Kovalszky I, Full\u00e1r A, Kiss K, Schaff Z, Iozzo RV, Baghy K (2014) Decorin deficiency promotes hepatic carcinogenesis. Matrix Biol 35:194\u2013205","journal-title":"Matrix Biol"},{"key":"195_CR36","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1177\/38.11.2212616","volume":"38","author":"P Bianco","year":"1990","unstructured":"Bianco P, Fisher LW, Young MF, Termine JD, Robey PG (1990) Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues. J Histochem Cytochem 38:1549\u20131563","journal-title":"J Histochem Cytochem"},{"key":"195_CR37","doi-asserted-by":"crossref","first-page":"23274","DOI":"10.1016\/S0021-9258(18)54493-8","volume":"266","author":"HT J\u00e4rvel\u00e4inen","year":"1991","unstructured":"J\u00e4rvel\u00e4inen HT, Kinsella MG, Wight TN, Sandell LJ (1991) Differential expression of small chondroitin\/dermatan sulfate proteoglycans, PG-I\/biglycan and PG-II\/decorin, by vascular smooth muscle and endothelial cells in culture. J Biol Chem 266:23274\u201323281","journal-title":"J Biol Chem"},{"key":"195_CR38","first-page":"1041","volume":"5","author":"LF Brown","year":"1999","unstructured":"Brown LF, Guidi AJ, Schnitt SJ, Van De Water L, Iruela-Arispe ML, Yeo TK, Tognazzi K, Dvorak HF (1999) Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clin Cancer Res 5:1041\u20131056","journal-title":"Clin Cancer Res"},{"key":"195_CR39","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/1096-9896(200011)192:3<313::AID-PATH694>3.0.CO;2-B","volume":"192","author":"E Leygue","year":"2000","unstructured":"Leygue E, Snell L, Dotzlaw H, Troup S, Hiller-Hitchcock T, Murphy LC, Roughley PJ, Watson PH (2000) Lumican and decorin are differentially expressed in human breast carcinoma. J Pathol 192:313\u2013320","journal-title":"J Pathol"},{"key":"195_CR40","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00418-012-1026-0","volume":"139","author":"P Bostr\u00f6m","year":"2013","unstructured":"Bostr\u00f6m P, Sainio A, Kakko T, Savontaus M, S\u00f6derstr\u00f6m M, J\u00e4rvel\u00e4inen H (2013) Localization of decorin gene expression in normal human breast tissue and in benign and malignant tumors of the human breast. Histochem Cell Biol 139:161\u2013171","journal-title":"Histochem Cell Biol"},{"key":"195_CR41","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/cam4.231","volume":"3","author":"B Bozoky","year":"2014","unstructured":"Bozoky B, Savchenko A, Guven H, Ponten F, Klein G, Szekely L (2014) Decreased decorin expression in the tumor microenvironment. Cancer Med 3:485\u2013491","journal-title":"Cancer Med"},{"key":"195_CR42","first-page":"207","volume":"9","author":"S Troup","year":"2003","unstructured":"Troup S, Njue C, Kliewer EV, Parisien M, Roskelley C, Chakravarti S, Roughley PJ, Murphy LC, Watson PH (2003) Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer. Clin Cancer Res 9:207\u2013214","journal-title":"Clin Cancer Res"},{"key":"195_CR43","first-page":"1939","volume":"7","author":"SJ Li","year":"2015","unstructured":"Li SJ, Chen DL, Zhang WB, Shen C, Che GW (2015) Prognostic value of stromal decorin expression in patients with breast cancer: a meta-analysis. J Thorac Dis 7:1939\u20131950","journal-title":"J Thorac Dis"},{"key":"195_CR44","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000228253","volume":"77","author":"K Araki","year":"2009","unstructured":"Araki K, Wakabayashi H, Shintani K, Morikawa J, Matsumine A, Kusuzaki K, Sudo A, Uchida A (2009) Decorin suppresses bone metastasis in a breast cancer cell line. Oncology 77:92\u201399","journal-title":"Oncology"},{"key":"195_CR45","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1089\/hum.2015.098","volume":"26","author":"Y Yang","year":"2015","unstructured":"Yang Y, Xu W, Neill T, Hu Z, Wang CH, Xiao X, Stock SR, Guise T, Yun CO, Brendler CB, Iozzo RV, Seth P (2015) Systemic delivery of an oncolytic adenovirus expressing Decorin for the treatment of breast cancer bone metastases. Hum Gene Ther 26:813\u2013825","journal-title":"Hum Gene Ther"},{"key":"195_CR46","volume":"2","author":"T Neill","year":"2015","unstructured":"Neill T, Schaefer L, Iozzo RV (2015) Oncosuppressive functions of decorin. Mol Cell Oncol 2:e975645","journal-title":"Mol Cell Oncol"},{"key":"195_CR47","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.addr.2015.10.016","volume":"97","author":"T Neill","year":"2016","unstructured":"Neill T, Schaefer L, Iozzo RV (2016) Decorin as a multivalent therapeutic agent against cancer. Adv Drug Deliv Rev 97:174\u2013185","journal-title":"Adv Drug Deliv Rev"},{"key":"195_CR48","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s13277-014-2779-y","volume":"36","author":"X Xing","year":"2015","unstructured":"Xing X, Gu X, Ma T, Ye H (2015) Biglycan up-regulated vascular endothelial growth factor (VEGF) expression and promoted angiogenesis in colon cancer. Tumour Biol 36:1773\u20131780","journal-title":"Tumour Biol"},{"key":"195_CR49","doi-asserted-by":"crossref","first-page":"28039","DOI":"10.1038\/srep28039","volume":"6","author":"N Maishi","year":"2016","unstructured":"Maishi N, Ohba Y, Akiyama K, Ohga N, Hamada J, Nagao-Kitamoto H, Alam MT, Yamamoto K, Kawamoto T, Inoue N, Taketomi A, Shindoh M, Hida Y, Hida K (2016) Tumour endothelial cells in high metastatic tumours promote metastasis via epigenetic dysregulation of biglycan. Sci Rep 6:28039","journal-title":"Sci Rep"},{"key":"195_CR50","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00404-015-3844-5","volume":"293","author":"H Sun","year":"2016","unstructured":"Sun H, Wang X, Zhang Y, Che X, Liu Z, Zhang L, Qiu C, Lv Q, Jiang J (2016) Biglycan enhances the ability of migration and invasion in endometrial cancer. Arch Gynecol Obstet 293:429\u2013438","journal-title":"Arch Gynecol Obstet"},{"key":"195_CR51","doi-asserted-by":"publisher","unstructured":"Andrlova H, Mastroianni J, Madl J, Kern JS, Melchinger W, Dierbach H, Wernet F, Follo M, Technau-Hafsi K, Has C, Mittapalli VR, Idzko M, Herr R, Brummer T, Ungefroren H, Busch H, Boerries M, Narr A, Ihorst G, Vennin C, Schmitt-Graeff A, Minguet S, Timpson P, Duyster J, Meiss F, Romer W, Zeiser R (2017) Biglycan expression in the melanoma microenvironment promotes invasiveness via increased tissue stiffness inducing integrin-beta1 expression. Oncotarget. doi: 10.18632\/oncotarget.17160","DOI":"10.18632\/oncotarget.17160"},{"key":"195_CR52","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1369\/jhc.2008.950287","volume":"56","author":"HH Salom\u00e4ki","year":"2008","unstructured":"Salom\u00e4ki HH, Sainio AO, S\u00f6derstr\u00f6m M, Pakkanen S, Laine J, J\u00e4rvel\u00e4inen HT (2008) Differential expression of decorin by human malignant and benign vascular tumors. J Histochem Cytochem 56:639\u2013646","journal-title":"J Histochem Cytochem"},{"key":"195_CR53","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00441-002-0683-z","volume":"311","author":"YH Zhuang","year":"2003","unstructured":"Zhuang YH, Saaristo R, Ylikomi T (2003) An in vitro long-term culture model for normal human mammary gland: expression and regulation of steroid receptors. Cell Tissue Res 311:217\u2013226","journal-title":"Cell Tissue Res"},{"key":"195_CR54","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/1471-2407-6-246","volume":"6","author":"N Eig\u0117lien\u0117","year":"2006","unstructured":"Eig\u0117lien\u0117 N, H\u00e4rk\u00f6nen P, Erkkola R (2006) Effects of estradiol and medroxyprogesterone acetate on morphology, proliferation and apoptosis of human breast tissue in organ cultures. BMC Cancer 6:246","journal-title":"BMC Cancer"},{"key":"195_CR55","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.4161\/cc.21195","volume":"11","author":"JL Dean","year":"2012","unstructured":"Dean JL, McClendon AK, Hickey TE, Butler LM, Tilley WD, Witkiewicz AK, Knudsen ES (2012) Therapeutic response to CDK4\/6 inhibition in breast cancer defined by ex vivo analyses of human tumors. Cell Cycle 11:2756\u20132761","journal-title":"Cell Cycle"},{"key":"195_CR56","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1365-2559.2004.01899.x","volume":"45","author":"X Sastre-Garau","year":"2004","unstructured":"Sastre-Garau X, Genin P, Rousseau A, Al Ghuzlan A, Nicolas A, Freneaux P, Rosty C, Sigal-Zafrani B, Couturier J, Thiery JP, Magdelenat H, Vincent-Salomon A (2004) Increased cell size and Akt activation in HER-2\/neu-overexpressing invasive ductal carcinoma of the breast. Histopathology 45:142\u2013147","journal-title":"Histopathology"},{"key":"195_CR57","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","volume":"31","author":"AC Wolff","year":"2013","unstructured":"Wolff AC, Hammond ME, Hicks DG, Dowsett M, McShane LM, Allison KH, Allred DC, Bartlett JM, Bilous M, Fitzgibbons P, Hanna W, Jenkins RB, Mangu PB, Paik S, Perez EA, Press MF, Spears PA, Vance GH, Viale G, Hayes DF, American Society of Clinical Oncology, College of American Pathologists (2013) Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update. J Clin Oncol 31:3997\u20134013","journal-title":"J Clin Oncol"},{"key":"195_CR58","first-page":"5346","volume":"9","author":"TT Junttila","year":"2003","unstructured":"Junttila TT, Laato M, Vahlberg T, Soderstrom KO, Visakorpi T, Isola J, Elenius K (2003) Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patients. Clin Cancer Res 9:5346\u20135357","journal-title":"Clin Cancer Res"},{"key":"195_CR59","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/sj.jcbfm.9600285","volume":"26","author":"M Santra","year":"2006","unstructured":"Santra M, Katakowski M, Zhang RL, Zhang ZG, Meng H, Jiang F, Chopp M (2006) Protection of adult mouse progenitor cells and human glioma cells by de novo decorin expression in an oxygen- and glucose-deprived cell culture model system. J Cereb Blood Flow Metab 26:1311\u20131322","journal-title":"J Cereb Blood Flow Metab"},{"key":"195_CR60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134111","volume":"10","author":"C Farace","year":"2015","unstructured":"Farace C, Oliver JA, Melguizo C, Alvarez P, Bandiera P, Rama AR, Malaguarnera G, Ortiz R, Madeddu R, Prados J (2015) Microenvironmental modulation of Decorin and Lumican in Temozolomide-resistant glioblastoma and neuroblastoma cancer stem-like cells. PLoS One 10:e0134111","journal-title":"PLoS One"},{"key":"195_CR61","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00264-010-0996-6","volume":"35","author":"B Kubista","year":"2011","unstructured":"Kubista B, Klinglmueller F, Bilban M, Pfeiffer M, Lass R, Giurea A, Funovics PT, Toma C, Dominkus M, Kotz R, Thalhammer T, Trieb K, Zettl T, Singer CF (2011) Microarray analysis identifies distinct gene expression profiles associated with histological subtype in human osteosarcoma. Int Orthop 35:401\u2013411","journal-title":"Int Orthop"},{"key":"195_CR62","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1158\/1541-7786.MCR-07-0165","volume":"6","author":"A Zafiropoulos","year":"2008","unstructured":"Zafiropoulos A, Nikitovic D, Katonis P, Tsatsakis A, Karamanos NK, Tzanakakis GN (2008) Decorin-induced growth inhibition is overcome through protracted expression and activation of epidermal growth factor receptors in osteosarcoma cells. Mol Cancer Res 6:785\u2013794","journal-title":"Mol Cancer Res"},{"key":"195_CR63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030992","volume":"7","author":"TR Cawthorn","year":"2012","unstructured":"Cawthorn TR, Moreno JC, Dharsee M, Tran-Thanh D, Ackloo S, Zhu PH, Sardana G, Chen J, Kupchak P, Jacks LM, Miller NA, Youngson BJ, Iakovlev V, Guidos CJ, Vallis KA, Evans KR, McCready D, Leong WL, Done SJ (2012) Proteomic analyses reveal high expression of decorin and endoplasmin (HSP90B1) are associated with breast cancer metastasis and decreased survival. PLoS One 7:e30992","journal-title":"PLoS One"},{"key":"195_CR64","first-page":"a005058","volume":"3","author":"P Lu","year":"2011","unstructured":"Lu P, Takai K, Weaver VM, Werb Z (2011) Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harb Perspect Biol 3:a005058","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"195_CR65","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/bcr287","volume":"3","author":"RA Walker","year":"2001","unstructured":"Walker RA (2001) The complexities of breast cancer desmoplasia. Breast Cancer Res 3:143\u2013145","journal-title":"Breast Cancer Res"},{"key":"195_CR66","doi-asserted-by":"publisher","unstructured":"Sainio A, J\u00e4rvel\u00e4inen H (2013) Extracellular matrix macromolecules in tumour microenvironment with special reference to desmoplastic reaction and the role of matrix proteoglycans and Hyaluronan. J Carcinog Mutagen. doi: 10.4172\/2157-2518.S13-002","DOI":"10.4172\/2157-2518.S13-002"},{"key":"195_CR67","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s10555-016-9650-0","volume":"35","author":"S Kaushik","year":"2016","unstructured":"Kaushik S, Pickup MW, Weaver VM (2016) From transformation to metastasis: deconstructing the extracellular matrix in breast cancer. Cancer Metastasis Rev 35:655\u2013667","journal-title":"Cancer Metastasis Rev"},{"key":"195_CR68","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/carcin\/bgr293","volume":"33","author":"X Bi","year":"2012","unstructured":"Bi X, Pohl NM, Qian Z, Yang GR, Gou Y, Guzman G, Kajdacsy-Balla A, Iozzo RV, Yang W (2012) Decorin-mediated inhibition of colorectal cancer growth and migration is associated with E-cadherin in vitro and in mice. Carcinogenesis 33:326\u2013330","journal-title":"Carcinogenesis"},{"key":"195_CR69","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1007\/s13277-015-4160-1","volume":"37","author":"Y Xu","year":"2016","unstructured":"Xu Y, Xia Q, Rao Q, Shi S, Shi Q, Ma H, Lu Z, Chen H, Zhou X (2016) DCN deficiency promotes renal cell carcinoma growth and metastasis through downregulation of P21 and E-cadherin. Tumour Biol 37:5171\u20135183","journal-title":"Tumour Biol"},{"key":"195_CR70","doi-asserted-by":"publisher","unstructured":"Liu Z, Yang Y, Zhang X, Wang H, Xu W, Wang H, Xiao F, Bai Z, Yao H, Ma X, Jin L, Wu CT, Seth P, Zhang Z, Wang L (2017) An oncolytic adenovirus encoding decorin and GM-CSF inhibits tumor growth in a colorectal tumor model by targeting pro-tumorigenic signals and via immune-activation. Hum Gene Ther. doi: 10.1089\/hum.2017.033","DOI":"10.1089\/hum.2017.033"},{"key":"195_CR71","doi-asserted-by":"publisher","unstructured":"Mak KY, Rajapaksha IG, Angus PW, Herath CB (2017) The adeno-associated virus - a safe and effective vehicle for liver-specific Gene therapy of inherited and non-inherited diseases. Curr Gene Ther. doi: 10.2174\/1566523217666170314141931","DOI":"10.2174\/1566523217666170314141931"},{"key":"195_CR72","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.tips.2012.04.005","volume":"33","author":"N Arnberg","year":"2012","unstructured":"Arnberg N (2012) Adenovirus receptors: implications for targeting of viral vectors. Trends Pharmacol Sci 33:442\u2013448","journal-title":"Trends Pharmacol Sci"},{"key":"195_CR73","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/gt.2011.213","volume":"20","author":"T Sasaki","year":"2013","unstructured":"Sasaki T, Tazawa H, Hasei J, Osaki S, Kunisada T, Yoshida A, Hashimoto Y, Yano S, Yoshida R, Kagawa S, Uno F, Urata Y, Ozaki T, Fujiwara T (2013) A simple detection system for adenovirus receptor expression using a telomerase-specific replication-competent adenovirus. Gene Ther 20:112\u2013118","journal-title":"Gene Ther"},{"key":"195_CR74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076190","volume":"8","author":"A Sainio","year":"2013","unstructured":"Sainio A, Nyman M, Lund R, Vuorikoski S, Bostr\u00f6m P, Laato M, Bostr\u00f6m PJ, J\u00e4rvel\u00e4inen H (2013) Lack of decorin expression by human bladder cancer cells offers new tools in the therapy of urothelial malignancies. PLoS One 8:e76190","journal-title":"PLoS One"},{"key":"195_CR75","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1369\/0022155415590830","volume":"63","author":"MC Nyman","year":"2015","unstructured":"Nyman MC, Sainio AO, Pennanen MM, Lund RJ, Vuorikoski S, Sundstr\u00f6m JT, J\u00e4rvel\u00e4inen HT (2015) Decorin in human Colon cancer: localization in vivo and effect on cancer cell behavior in vitro. J Histochem Cytochem 63:710\u2013720","journal-title":"J Histochem Cytochem"},{"key":"195_CR76","first-page":"1533","volume":"19","author":"K Shintani","year":"2008","unstructured":"Shintani K, Matsumine A, Kusuzaki K, Morikawa J, Matsubara T, Wakabayashi T, Araki K, Satonaka H, Wakabayashi H, Iino T, Uchida A (2008) Decorin suppresses lung metastases of murine osteosarcoma. Oncol Rep 19:1533\u20131539","journal-title":"Oncol Rep"},{"key":"195_CR77","doi-asserted-by":"crossref","first-page":"32468","DOI":"10.1074\/jbc.M503833200","volume":"280","author":"JX Zhu","year":"2005","unstructured":"Zhu JX, Goldoni S, Bix G, Owens RT, McQuillan DJ, Reed CC, Iozzo RV (2005) Decorin evokes protracted internalization and degradation of the epidermal growth factor receptor via caveolar endocytosis. J Biol Chem 280:32468\u201332479","journal-title":"J Biol Chem"},{"key":"195_CR78","doi-asserted-by":"crossref","first-page":"844","DOI":"10.2353\/ajpath.2008.080275","volume":"173","author":"S Goldoni","year":"2008","unstructured":"Goldoni S, Seidler DG, Heath J, Fassan M, Baffa R, Thakur ML, Owens RT, McQuillan DJ, Iozzo RV (2008) An antimetastatic role for decorin in breast cancer. Am J Pathol 173:844\u2013855","journal-title":"Am J Pathol"},{"key":"195_CR79","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1615\/CritRevOncog.v17.i1.40","volume":"17","author":"NS Dhomen","year":"2012","unstructured":"Dhomen NS, Mariadason J, Tebbutt N, Scott AM (2012) Therapeutic targeting of the epidermal growth factor receptor in human cancer. Crit Rev Oncog 17:31\u201350","journal-title":"Crit Rev Oncog"},{"key":"195_CR80","doi-asserted-by":"crossref","first-page":"17406","DOI":"10.1074\/jbc.M710025200","volume":"283","author":"LR Fiedler","year":"2008","unstructured":"Fiedler LR, Sch\u00f6nherr E, Waddington R, Niland S, Seidler DG, Aeschlimann D, Eble JA (2008) Decorin regulates endothelial cell motility on collagen I through activation of insulin-like growth factor I receptor and modulation of alpha2beta1 integrin activity. J Biol Chem 283:17406\u201317415","journal-title":"J Biol Chem"},{"key":"195_CR81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050809","volume":"7","author":"O Jungmann","year":"2012","unstructured":"Jungmann O, Nikolovska K, Stock C, Schulz JN, Eckes B, Riethmuller C, Owens RT, Iozzo RV, Seidler DG (2012) The dermatan sulfate proteoglycan decorin modulates alpha2beta1 integrin and the vimentin intermediate filament system during collagen synthesis. PLoS One 7:e50809","journal-title":"PLoS One"},{"key":"195_CR82","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/01.RES.87.6.434","volume":"87","author":"S Dimmeler","year":"2000","unstructured":"Dimmeler S, Zeiher AM (2000) Endothelial cell apoptosis in angiogenesis and vessel regression. Circ Res 87:434\u2013439","journal-title":"Circ Res"},{"key":"195_CR83","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.matbio.2015.01.023","volume":"43","author":"H J\u00e4rvel\u00e4inen","year":"2015","unstructured":"J\u00e4rvel\u00e4inen H, Sainio A, Wight TN (2015) Pivotal role for decorin in angiogenesis. Matrix Biol 43:15\u201326","journal-title":"Matrix Biol"},{"key":"195_CR84","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1074\/jbc.M113.512566","volume":"289","author":"T Neill","year":"2014","unstructured":"Neill T, Torres A, Buraschi S, Owens RT, Hoek JB, Baffa R, Iozzo RV (2014) Decorin induces mitophagy in breast carcinoma cells via peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha) and mitostatin. J Biol Chem 289:4952\u20134968","journal-title":"J Biol Chem"},{"key":"195_CR85","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/PPO.0000000000000140","volume":"21","author":"CJ Whatcott","year":"2015","unstructured":"Whatcott CJ, Han H, Von Hoff DD (2015) Orchestrating the tumor microenvironment to improve survival for patients with pancreatic cancer: normalization, not destruction. Cancer J 21:299\u2013306","journal-title":"Cancer J"},{"key":"195_CR86","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.15252\/embr.201439246","volume":"15","author":"MW Pickup","year":"2014","unstructured":"Pickup MW, Mouw JK, Weaver VM (2014) The extracellular matrix modulates the hallmarks of cancer. EMBO Rep 15:1243\u20131253","journal-title":"EMBO Rep"},{"key":"195_CR87","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.addr.2015.12.017","volume":"97","author":"J Insua-Rodriguez","year":"2016","unstructured":"Insua-Rodriguez J, Oskarsson T (2016) The extracellular matrix in breast cancer. Adv Drug Deliv Rev 97:41\u201355","journal-title":"Adv Drug Deliv Rev"}],"container-title":["Cancer Microenvironment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12307-017-0195-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12307-017-0195-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12307-017-0195-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T01:37:35Z","timestamp":1659145055000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12307-017-0195-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,26]]},"references-count":87,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["195"],"URL":"https:\/\/doi.org\/10.1007\/s12307-017-0195-8","relation":{},"ISSN":["1875-2292","1875-2284"],"issn-type":[{"value":"1875-2292","type":"print"},{"value":"1875-2284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,26]]}}}